In contrast, CD4+ and CD8+-depleted mice showed an accelerated tumor growth, reaching a maximum growth by days 65 and 47, respectively, and a mortality rate of 100% in both treatments (Figure 4B, right panel). Here, CD8A is linked to neoplasm.